The Technology
Manipulating the activity of the endocannabinoid system (ECS) offers therapeutic potential for a multitude of pathological conditions affecting humans. ECS receptors such as cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) have been found to be expressed in the skin. Thus, various strains of Cannabis sativa and its derivatives, the cannabinoids, have gained substantial interest as a potential therapeutic avenue for treating wounds and/or induce skin regeneration. Nevertheless, there is still a great need for compositions suitable for wound healing and/or regenerating skin. The invention identifies specific cannabinoid compositions, which induced faster wound closure, increased epidermal invaginations within the treated wound site, and increased cell proliferation, and therefore, is of relevancy for the treatment of a wound and/or skin regeneration, as well as skin pathologies therapy (i.e. Acne Vulgaris and Psoriasis).
Advantages
- Current medicines can cause different side effects and there is no one-size-fits-all therapy for these indications.
- Strong effects of the indicated combinations that could lead to new treatments protocols and regimes.
Applications and Opportunities
- Wound healing.
- Hair follicle and sebaceous gland regeneration.
- Improve scaring.
- Skin nourishment.
- Other Skin pathologies.
Business Development Contacts